open access

Vol 5, No 2 (2002)
Published online: 2002-06-07
Submitted: 2012-01-23
Get Citation

The diagnostics of recurrent gliomas using FDG-PET: still questionable?

Otakar Belohlávek, Jan Klener, Josef Vymazal, Vladimir Dbaly, František Tovaryš
Nucl. Med. Rev 2002;5(2):127-130.

open access

Vol 5, No 2 (2002)
Published online: 2002-06-07
Submitted: 2012-01-23

Abstract

BACKGROUND: For a number of years, FDG-PET was considered as a gold standard for the differential diagnosis of recurrent glioma and radionecrosis. Recently published papers have introduced a wealth of scepticism into this area. The aim of this work is to specify the added value of FDG PET, as compared to MRI, in terms of diagnostics of recurrent gliomas in the clinical setting of the PET Centre Prague.
MATERIAL AND METHODS: MRI and FDG-PET were used to examine 29 patients for suspicious glioma recurrence, after 30 open neurosurgical operations or re-operations combined with chemo- and/or radiotherapy. The sensitivity, specificity and accuracy of both examinations were calculated with respect to their micromorphological findings (n = 28) or the clinical and radiological follow-up (n = 2).
RESULTS: MRI detected 23/24 tumour recurrences (sensitivity = 95.8%) and FDG PET only 15 of these (sensitivity = 62.5%). MRI specified only 3/6 radionecrotic lesions (specificity = 50.0%), while FDG PET identified 5/6 (specificity = 83.3%). Overall accuracy was 26/30 (86.7%) for MRI and 20/30 (66.7%) for FDG PET. In the subgroup of MRI positive or equivocal findings (n = 29) FDG PET was clearly positive in 15 cases. High-grade glioma recurrence was subsequently confirmed in all of them. On the other hand negative or equivocal FDG PET was associated in 5/14 cases (35.7%) with radionecrosis, in 3/14 (21.4%) with low-grade glioma and in 6/14 (42.9%) with high-grade glioma.
CONCLUSIONS: MRI is the method of choice for the detection of glioma recurrence but it is associated with a high rate of false positive results. FDG PET has significantly lower sensitivity; nevertheless it does help to specify MRI positive lesions. FDG PET positive lesions give a very high probability of high-grade glioma, but its equivocal and negative findings are of no clinical value.

Abstract

BACKGROUND: For a number of years, FDG-PET was considered as a gold standard for the differential diagnosis of recurrent glioma and radionecrosis. Recently published papers have introduced a wealth of scepticism into this area. The aim of this work is to specify the added value of FDG PET, as compared to MRI, in terms of diagnostics of recurrent gliomas in the clinical setting of the PET Centre Prague.
MATERIAL AND METHODS: MRI and FDG-PET were used to examine 29 patients for suspicious glioma recurrence, after 30 open neurosurgical operations or re-operations combined with chemo- and/or radiotherapy. The sensitivity, specificity and accuracy of both examinations were calculated with respect to their micromorphological findings (n = 28) or the clinical and radiological follow-up (n = 2).
RESULTS: MRI detected 23/24 tumour recurrences (sensitivity = 95.8%) and FDG PET only 15 of these (sensitivity = 62.5%). MRI specified only 3/6 radionecrotic lesions (specificity = 50.0%), while FDG PET identified 5/6 (specificity = 83.3%). Overall accuracy was 26/30 (86.7%) for MRI and 20/30 (66.7%) for FDG PET. In the subgroup of MRI positive or equivocal findings (n = 29) FDG PET was clearly positive in 15 cases. High-grade glioma recurrence was subsequently confirmed in all of them. On the other hand negative or equivocal FDG PET was associated in 5/14 cases (35.7%) with radionecrosis, in 3/14 (21.4%) with low-grade glioma and in 6/14 (42.9%) with high-grade glioma.
CONCLUSIONS: MRI is the method of choice for the detection of glioma recurrence but it is associated with a high rate of false positive results. FDG PET has significantly lower sensitivity; nevertheless it does help to specify MRI positive lesions. FDG PET positive lesions give a very high probability of high-grade glioma, but its equivocal and negative findings are of no clinical value.
Get Citation

Keywords

glioma; recurrence; radionecrosis; FDG; PET

About this article
Title

The diagnostics of recurrent gliomas using FDG-PET: still questionable?

Journal

Nuclear Medicine Review

Issue

Vol 5, No 2 (2002)

Pages

127-130

Published online

2002-06-07

Bibliographic record

Nucl. Med. Rev 2002;5(2):127-130.

Keywords

glioma
recurrence
radionecrosis
FDG
PET

Authors

Otakar Belohlávek
Jan Klener
Josef Vymazal
Vladimir Dbaly
František Tovaryš

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl